These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3710517)

  • 1. Cytolysis of actinomycin D-treated target cells by cell-free supernatants from human monocytes.
    McKinnon KP; Chen AR; Argov S; Lane BC; Koren HS
    Immunobiology; 1986 Mar; 171(1-2):27-44. PubMed ID: 3710517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR; McKinnon KP; Koren HS
    J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of monocyte cytotoxic factor in cytolysis of actinomycin D-treated WEHI 164 cells mediated by freshly isolated human adherent mononuclear blood cells.
    Austgulen R; Espevik T; Hammerstrøm J; Nissen-Meyer J
    Cancer Res; 1986 Sep; 46(9):4566-70. PubMed ID: 3524816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
    J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid killing of actinomycin D-treated tumor cells--cytotoxicity of cell-free monocyte supernatants.
    Bersani L; Colotta F; Ghezzi P; Mantovani A
    Immunol Lett; 1985; 11(5-6):351-5. PubMed ID: 4093154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monocyte cytotoxic factor mediates cytolysis of WEHI 164 cells.
    Austgulen R; Hammerstrøm J; Espevik T; Nissen-Meyer J
    Cell Immunol; 1986 Mar; 98(1):211-20. PubMed ID: 3461886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
    Kornbluth RS; Edgington TS
    J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
    Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
    Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monocyte-mediated tumor cytotoxicity. I. Demonstration of an oxygen-dependent myeloperoxidase-independent mechanism.
    Mavier P; Edgington TS
    J Immunol; 1984 Apr; 132(4):1980-6. PubMed ID: 6321594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon.
    Fischer DG; Golightly MG; Koren HS
    J Immunol; 1983 Mar; 130(3):1220-5. PubMed ID: 6401781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid extremely sensitive, quantitative microassay for cytotoxic cytokines.
    Klostergaard J
    Lymphokine Res; 1985; 4(4):309-17. PubMed ID: 3876491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of tumour necrosis factor in monocyte-mediated rapid killing of actinomycin D-pretreated WEHI 164 sarcoma cells.
    Bersani L; Colotta F; Mantovani A
    Immunology; 1986 Oct; 59(2):323-5. PubMed ID: 3770807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of phorbol ester-mediated reduction of cloned T lymphocyte cytolysis by interleukin 2.
    Orosz CG; Scott JW; Gillis S; Finke JH
    J Immunol; 1985 Jan; 134(1):324-9. PubMed ID: 3871104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WEHI-164 clone 2F: in vitro antitumor effects of tumor necrosis factor and gamma-interferon.
    Lattime EC; Stutman O
    Nat Immun; 1992; 11(1):34-45. PubMed ID: 1611280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic effector function of B lymphoblasts.
    Bersani L; Colotta F; Peri G; Mantovani A
    J Immunol; 1987 Jul; 139(2):645-8. PubMed ID: 3496385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
    Richter M; Banerjee D; Sklar S
    Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET; Babbitt JT; Kawakami K
    J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.